Published in Cancer Metastasis Rev on January 01, 1987
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A (1998) 7.78
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell (2012) 7.57
Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov (2010) 7.48
Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol (2010) 7.26
Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol (2000) 5.94
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci U S A (1996) 5.04
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A (1991) 4.85
Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J Clin Oncol (2013) 4.23
Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res (2007) 3.64
Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res (2007) 3.45
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev (2013) 3.44
Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc Natl Acad Sci U S A (1989) 2.61
Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res (2009) 2.32
Vascularization strategies for tissue engineering. Tissue Eng Part B Rev (2009) 2.31
Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules. Proc Natl Acad Sci U S A (1999) 1.82
Interstitial flow influences direction of tumor cell migration through competing mechanisms. Proc Natl Acad Sci U S A (2011) 1.81
Imaging angiogenesis and the microenvironment. APMIS (2008) 1.77
Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest (1998) 1.72
Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release (2005) 1.68
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors. Neuro Oncol (2008) 1.59
Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia (2001) 1.56
A simple method for measuring interstitial fluid pressure in cancer tissues. Microvasc Res (2005) 1.55
Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice. Cancer Res (2010) 1.49
Strategies for advancing cancer nanomedicine. Nat Mater (2013) 1.48
Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease. AAPS J (2009) 1.48
State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. J Control Release (2014) 1.46
The role of mechanical forces in tumor growth and therapy. Annu Rev Biomed Eng (2014) 1.40
Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. Neuro Oncol (2007) 1.39
Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice. Proc Natl Acad Sci U S A (1994) 1.36
Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am J Pathol (1997) 1.31
Challenges in development of nanoparticle-based therapeutics. AAPS J (2012) 1.28
Transport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest (2014) 1.26
The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems. J Theor Biol (2012) 1.25
Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia (2000) 1.25
Intraperitoneal therapy for peritoneal cancer. Future Oncol (2010) 1.25
Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer. Proc Natl Acad Sci U S A (2001) 1.22
Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats. Radiology (2008) 1.17
Targeting vault nanoparticles to specific cell surface receptors. ACS Nano (2009) 1.13
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors. J Transl Med (2009) 1.11
Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer (1999) 1.11
Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models. Cancer Res (2011) 1.10
Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours. BMC Cancer (2008) 1.07
Dynamic visualization of RGD-quantum dot binding to tumor neovasculature and extravasation in multiple living mouse models using intravital microscopy. Small (2010) 1.05
A tumor cord model for doxorubicin delivery and dose optimization in solid tumors. Theor Biol Med Model (2009) 1.05
Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis. Br J Cancer (2003) 1.05
Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev (2012) 1.04
Tumor-immune interaction, surgical treatment, and cancer recurrence in a mathematical model of melanoma. PLoS Comput Biol (2009) 1.02
Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. Adv Drug Deliv Rev (2010) 1.02
Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods. Proc IEEE Inst Electr Electron Eng (2005) 1.02
Advances of cancer therapy by nanotechnology. Cancer Res Treat (2009) 1.01
Surgical resection of solitary metastasis of malignant melanoma to the right atrium. Tex Heart Inst J (2010) 1.00
Stromal reengineering to treat pancreas cancer. Carcinogenesis (2014) 1.00
An integrated approach for the rational design of nanovectors for biomedical imaging and therapy. Adv Genet (2010) 1.00
Magnetic nanoparticle drug carriers and their study by quadrupole magnetic field-flow fractionation. Mol Pharm (2009) 0.99
Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study. Br J Cancer (1996) 0.99
Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier. Int J Cancer (2010) 0.98
A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance. Neoplasia (2004) 0.97
Liposomal daunorubicin as treatment for Kaposi's sarcoma. Int J Nanomedicine (2007) 0.97
A mathematical model of tumour and blood pHe regulation: The HCO3-/CO2 buffering system. Math Biosci (2010) 0.97
The billion cell construct: will three-dimensional printing get us there? PLoS Biol (2014) 0.96
Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model. Ann Biomed Eng (2012) 0.95
Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors. J Transl Med (2009) 0.95
Numerical modeling of fluid flow in solid tumors. PLoS One (2011) 0.95
Increased plasma colloid osmotic pressure facilitates the uptake of therapeutic macromolecules in a xenograft tumor model. Neoplasia (2009) 0.94
Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression. Adv Mater (2013) 0.94
Modeling of nanotherapeutics delivery based on tumor perfusion. New J Phys (2013) 0.94
Biological rationale for the design of polymeric anti-cancer nanomedicines. J Drug Target (2012) 0.93
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities. Adv Drug Deliv Rev (2013) 0.92
Novel membrane-permeable contrast agent for brain tumor detection by MRI. Magn Reson Med (2010) 0.92
High interstitial fluid pressure is associated with tumor-line specific vascular abnormalities in human melanoma xenografts. PLoS One (2012) 0.91
Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507. Clin Cancer Res (2011) 0.91
An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer. Eur Radiol (2010) 0.91
In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour. Br J Cancer (1999) 0.90
Predicting the safety and efficacy of buffer therapy to raise tumour pHe: an integrative modelling study. Br J Cancer (2012) 0.90
Effects of radiotherapy and estramustine on the microvasculature in malignant glioma. Br J Cancer (1999) 0.89
Effect of tumor shape and size on drug delivery to solid tumors. J Biol Eng (2012) 0.89
From the Guest Editors: Role of Tumor Microenvironment in Tumor Progression and Treatment Response: A 30 Years' Journey. Cancer J (2015) 0.88
Nanoparticle formulation of ormeloxifene for pancreatic cancer. Biomaterials (2015) 0.88
Immunotoxins and anticancer drug conjugate assemblies: the role of the linkage between components. Toxins (Basel) (2011) 0.87
Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment. Cancer Res (2014) 0.87
Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy. Front Oncol (2015) 0.86
Multifunctional polymeric micelles for delivery of drugs and siRNA. Front Pharmacol (2014) 0.86
Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines. Bioimpacts (2014) 0.86
Continuing pursuit for ideal systemic anticancer radiotherapeutics. Invest New Drugs (2011) 0.86
In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer. Adv Drug Deliv Rev (2013) 0.85
Sensitivity analysis of an image-based solid tumor computational model with heterogeneous vasculature and porosity. Ann Biomed Eng (2011) 0.85
Boron delivery with liposomes for boron neutron capture therapy (BNCT): biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potential. Radiat Environ Biophys (2012) 0.85
Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats rhabdomyosarcoma. Eur Radiol (2005) 0.85
A mathematical model of the enhanced permeability and retention effect for liposome transport in solid tumors. PLoS One (2013) 0.84
Magnetic resonance characterization of tumor microvessels in experimental breast tumors using a slow clearance blood pool contrast agent (carboxymethyldextran-A2-Gd-DOTA) with histopathological correlation. Eur Radiol (2005) 0.84
Polymer nanostructures synthesized by controlled living polymerization for tumor-targeted drug delivery. J Control Release (2015) 0.84
Drug conjugates such as Antibody Drug Conjugates (ADCs), immunotoxins and immunoliposomes challenge daily clinical practice. Int J Mol Sci (2012) 0.83
Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma. Br J Cancer (1995) 0.83
Radiation-induced changes in microcirculation and interstitial fluid pressure affecting the delivery of macromolecules and nanotherapeutics to tumors. Front Oncol (2012) 0.82
Molecular targeting of angiogenesis for imaging and therapy. Eur J Nucl Med Mol Imaging (2004) 0.82
Uses and limitations of monoclonal antibodies (MoAbs) in the treatment of malignant disease: a review. J R Soc Med (1993) 0.82
Dynamic contrast-enhanced MRI using macromolecular contrast media for monitoring the response to isolated limb perfusion in experimental soft-tissue sarcomas. MAGMA (2004) 0.81
Deep in vivo two-photon imaging of blood vessels with a new dye encapsulated in pluronic nanomicelles. J Biomed Opt (2011) 0.81
Pharmacokinetic analysis of the microscopic distribution of enzyme-conjugated antibodies and prodrugs: comparison with experimental data. Br J Cancer (1996) 0.81
Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev (1990) 2.75
Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst (1989) 2.62
Haemodynamic and transport barriers to the treatment of solid tumours. Int J Radiat Biol (1991) 1.33
Transvascular and interstitial transport in tumors. Adv Exp Med Biol (1988) 0.87
Dynamics of cancer cell interactions with microvasculature and interstitium. Biorheology (1987) 0.79